Navigation Links
ENA Single Well Screen

ProductsENA Single Well Screen
Company Alpha Laboratories Limited
Item ENA Single Well Screen
Features 
Description This is an enzyme immunoassay(EIA) test system for the detecton of antibodies to extractable nuclear antigens Sm, RNP, SSA, SSB, Scl-70 and Jo-1 in human serum. The results from this assay can be used as an aid in the diagnosis of autoimmune disease. This product is CE Marked.
Info Alpha Laboratories Limited
Customer Service: 0800 387 732
Web site:

Related medicine products :

1. Single Skin Hook
2. Single Tantalum Clip (50 Style)
3. Single Beam
4. Single Plate Molteno Implant (S1)
5. Pressure Ridge Single Plate Molteno Implant (D1)
6. Cottle Single Hook
7. Goldman Single Hook
8. Joseph Single Hook
9. Kleinert-Kutz Single Skin Hook
10. Ocular Single Mirror Gonio
11. Eye Vee 2.0 Single Wall Mount Rod Clear
Other Medicine News:Health News:Cardiff scientists study acute infection in end-stage kidney disease patients 2Health News:Statement by the National Patient Advocate Foundation on President-Elect Obama's Victory 2Health News:Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics, According to Ernst & Young Report 2Health News:Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics, According to Ernst & Young Report 3Health News:Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics, According to Ernst & Young Report 4Health News:Conrad J. Heilman to Succeed Joseph S. Tempio as President and CEO of Tunnell Consulting 2Health News:Conrad J. Heilman to Succeed Joseph S. Tempio as President and CEO of Tunnell Consulting 3Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 2Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 3Health News:GLEH LA, a Nonprofit Affiliate of Gay & Lesbian Elder Housing, Announces New Program Director 2Health News:GLEH LA, a Nonprofit Affiliate of Gay & Lesbian Elder Housing, Announces New Program Director 3
Breaking Medicine Technology:NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Zimmer Holdings to Present at BMO Capital Markets Ninth Annual Focus on Healthcare Conference 53086 1Less Common Procedures Less Common Than Thought 53082 1Less Common Procedures Less Common Than Thought 53082 2Carboxytherapy and Mesotherapy Unproven Warns The Physicians Coalition for Injectable Safety 53079 1Carboxytherapy and Mesotherapy Unproven Warns The Physicians Coalition for Injectable Safety 53079 2Carboxytherapy and Mesotherapy Unproven Warns The Physicians Coalition for Injectable Safety 53079 3